Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
9 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Quince Therapeutics, Inc.’s names, not what it holds today.
Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
14
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry3
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
CORTEXYME, INC. a former name
US, as the owner printed on each patent
12 publishedCortexyme, Inc. a former name
named as the applicant on its applications, in US
2 publishedNames not counted (2)
Quince Therapeutics, Inc.
Most of its patents print IT; this name counts in US. 1 granted and 2 published under it are not counted.
Quince Therapeutics, Inc.
Most of its patents print IT; this name counts in US. 0 granted and 3 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 17, 2022 | 11,332,464 | Inhibitors of lysine gingipain | Pharmaceuticals | CORTEXYME, INC. |
| May 10, 2022 | 11,325,884 | Ketone inhibitors of lysine gingipain | Organic fine chemistry | CORTEXYME, INC. |
| Jul 13, 2021 | 11,059,786 | Aminopyridine compounds and methods for the preparation and use thereof | Organic fine chemistry | CORTEXYME, INC. |
| Feb 2, 2021 | 10,906,881 | Inhibitors of arginine gingipain | Organic fine chemistry | CORTEXYME, INC. |
| Aug 4, 2020 | 10,730,826 | Ketone inhibitors of lysine gingipain | Organic fine chemistry | CORTEXYME, INC. |
| Jun 9, 2020 | 10,676,470 | Inhibitors of lysine gingipain | Pharmaceuticals | CORTEXYME, INC. |
| May 28, 2019 | 10,301,301 | Inhibitors of lysine gingipain | Pharmaceuticals | CORTEXYME, INC. |
| Jun 5, 2018 | 9,988,375 | Inhibitors of lysine gingipain | Pharmaceuticals | CORTEXYME, INC. |
| Sep 12, 2017 | 9,758,473 | Inhibitors of lysine gingipain | Pharmaceuticals | CORTEXYME, INC. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| May 11, 2023 | 2023/0142714 | KETONE INHIBITORS OF LYSINE GINGIPAIN | Organic fine chemistry | CORTEXYME, INC. · patent 12,110,263 granted from it |
| Jun 30, 2022 | 2022/0204457 | ARGININE GINGIPAIN INHIBITORS | Organic fine chemistry | Cortexyme, Inc. |
| Nov 18, 2021 | 2021/0355527 | METHODS FOR DETECTION OF MICROBIAL NUCLEIC ACIDS IN BODY FLUIDS | Biotechnology | CORTEXYME, INC. |
| Nov 4, 2021 | 2021/0340105 | AMINOPYRIDINE COMPOUNDS AND METHODS FOR THE PREPARATION AND USE THEREOF | Organic fine chemistry | CORTEXYME, INC. |
| Feb 25, 2021 | 2021/0053908 | KETONE INHIBITORS OF LYSINE GINGIPAIN | Organic fine chemistry | CORTEXYME, INC. · patent 11,325,884 granted from it |
| Jan 21, 2021 | 2021/0017167 | INHIBITORS OF LYSINE GINGIPAIN | Pharmaceuticals | CORTEXYME, INC. · patent 11,332,464 granted from it |
| May 14, 2020 | 2020/0148642 | AMINOPYRIDINE COMPOUNDS AND METHODS FOR THE PREPARATION AND USE THEREOF | Organic fine chemistry | CORTEXYME, INC. · patent 11,059,786 granted from it |
| Oct 24, 2019 | 2019/0322659 | INHIBITORS OF LYSINE GINGIPAIN | Pharmaceuticals | CORTEXYME, INC. · patent 10,676,470 granted from it |
| Jul 11, 2019 | 2019/0210960 | KETONE INHIBITORS OF LYSINE GINGIPAIN | Organic fine chemistry | CORTEXYME, INC. · patent 10,730,826 granted from it |
| Dec 6, 2018 | 2018/0346460 | INHIBITORS OF LYSINE GINGIPAIN | Pharmaceuticals | CORTEXYME, INC. · patent 10,301,301 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.